These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9174193

  • 1. In vitro activity of HSR-903, a new quinolone.
    Takahashi Y, Masuda N, Otsuki M, Miki M, Nishino T.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1326-30. PubMed ID: 9174193
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial activity of DV-7751a, a new fluoroquinolone.
    Tanaka M, Hoshino K, Ishida H, Sato K, Hayakawa I, Osada Y.
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2112-8. PubMed ID: 8257132
    [Abstract] [Full Text] [Related]

  • 3. In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates.
    Tanaka M, Yamazaki E, Chiba M, Yoshihara K, Akasaka T, Takemura M, Sato K.
    Antimicrob Agents Chemother; 2002 Mar; 46(3):904-8. PubMed ID: 11850285
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
    Hoogkamp-Korstanje JA.
    J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activity of four new fluoroquinolones.
    García-Rodríguez JA, García Sánchez JE, García García MI, Fresnadillo MJ, Trujillano I, García Sánchez E.
    J Antimicrob Chemother; 1994 Jul; 34(1):53-64. PubMed ID: 7961215
    [Abstract] [Full Text] [Related]

  • 6. In vitro antibacterial activity of Q-35, a new fluoroquinolone.
    Ito T, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1708-14. PubMed ID: 1329626
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of BAY 12-8039, a new fluoroquinolone.
    Woodcock JM, Andrews JM, Boswell FJ, Brenwald NP, Wise R.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
    Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
    Bongaerts GP, Hoogkamp-Korstanje JA.
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2017-9. PubMed ID: 8239624
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.
    Gootz TD, Brighty KE, Anderson MR, Schmieder BJ, Haskell SL, Sutcliffe JA, Castaldi MJ, McGuirk PR.
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):235-43. PubMed ID: 7851087
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.
    Dalhoff A, Petersen U, Endermann R.
    Chemotherapy; 1996 Aug; 42(6):410-25. PubMed ID: 8957575
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria.
    Cohen MA, Huband MD, Mailloux GB, Yoder SL, Roland GE, Heifetz CL.
    Diagn Microbiol Infect Dis; 1991 Aug; 14(5):403-15. PubMed ID: 1665775
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone.
    Masuda N, Takahashi Y, Otsuki M, Ibuki E, Miyoshi H, Nishino T.
    Antimicrob Agents Chemother; 1996 May; 40(5):1201-7. PubMed ID: 8723467
    [Abstract] [Full Text] [Related]

  • 14. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 May; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.
    Wakebe H, Mitsuhashi S.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2185-91. PubMed ID: 1332589
    [Abstract] [Full Text] [Related]

  • 16. In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.
    Bremm KD, Petersen U, Metzger KG, Endermann R.
    Chemotherapy; 1992 Oct; 38(6):376-87. PubMed ID: 1288961
    [Abstract] [Full Text] [Related]

  • 17. In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone.
    Nilius AM, Shen LL, Hensey-Rudloff D, Almer LS, Beyer JM, Balli DJ, Cai Y, Flamm RK.
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3260-9. PubMed ID: 14506039
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.